Study Finds High Levels of Iron in the Brains of People Diagnosed with Down Syndrome and Alzheimer's
7 Articles
7 Articles
Iron imbalance in neurodegeneration
Iron is an essential element for the development and functionality of the brain, and anomalies in its distribution and concentration in brain tissue have been found to be associated with the most frequent neurodegenerative diseases. When magnetic resonance techniques allowed iron quantification in vivo, it was confirmed that the alteration of brain iron homeostasis is a common feature of many neurodegenerative diseases. However, whether iron is …
Almost a million people in Spain suffer from Alzheimer's disease, and it is expected that the figure will grow very significantly over the next few years. Therefore, there is a great interest at the public health level in the implementation of preventive interventions that help reduce the burden that pathology represents on an individual and social level.In many cases, these preventive strategies go through certain lifestyle changes aimed at ado…
Study finds high levels of iron in the brains of people diagnosed with Down syndrome and Alzheimer's
Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the brain and increased cell damage in people who have both Down syndrome and Alzheimer's disease.
Iron levels may play a major role in Down syndrome-associated Alzheimer's disease
Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the brain and increased cell damage in people who have both Down syndrome and Alzheimer's disease.
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer’s Disease clinical trial (NCT03671...
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium